Encompass Health (EHC)
(Delayed Data from NYSE)
$94.50 USD
-0.23 (-0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $94.48 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$94.50 USD
-0.23 (-0.24%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $94.48 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Zacks News
Centene's (CNC) Q4 Earnings Miss Estimates, Improve Y/Y
by Zacks Equity Research
Centene's (CNC) fourth-quarter results gain traction from better revenues.
What's in the Cards for Centene's (CNC) Earnings in Q4?
by Zacks Equity Research
Centene's (CNC) Q4 earnings results are likely to reflect membership growth and better revenues.
Encompass Health (EHC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investor Pick Encompass Health (EHC) Stock Now?
by Zacks Equity Research
Let's see if Encompass Health Corporation (EHC) stock is a good choice for value-oriented investors right now from multiple angles.
Why Encompass Health Corporation (EHC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Encompass Health Corporation (EHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should Value Investors Buy Encompass Health (EHC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EHC or USPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. USPH: Which Stock Is the Better Value Option?
Will Select Medical's Solid Run in 2019 Sustain in 2020?
by Zacks Equity Research
Acquisitions, partnerships and growth in admissions to drive Select Medical's (SEM) performance in 2020.
Encompass Health (EHC) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 4.49% and 0.57%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Can Value Investors Consider Encompass Health (EHC) Stock?
by Zacks Equity Research
Encompass Health (EHC) stock may be a good choice for value-oriented investors right now from multiple angles.
Encompass Health (EHC) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 11.34% and 0.02%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Encompass Health (EHC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EHC or USPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EHC vs. USPH: Which Stock Is the Better Value Option?
Analysts Estimate Encompass Health (EHC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health (EHC) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Encompass Health (EHC) delivered earnings and revenue surprises of 1.27% and 0.41%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Encompass Health (EHC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Encompass Health (EHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Encompass Health (EHC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Healthcare Stocks Likely to Beat Estimates in Q4
by Zacks Equity Research
An aging population, prevalence of chronic health conditions and greater utilization of healthcare services should drive the industry's growth, partly offset by an increase in expenses.
Cigna (CI) Poised to Beat Q4 Earnings on Revenue Growth
by Zacks Equity Research
Cigna's (CI) Q4 results are likely to gain from increase in revenues and membership.
Zacks.com featured highlights include: Allison Transmission, Restoration Hardware, Cigna, Encompass Health and O???Reilly Automotive
by Zacks Equity Research
Zacks.com featured highlights include: Allison Transmission, Restoration Hardware, Cigna, Encompass Health and O???Reilly Automotive
5 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Encompass Health Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Encompass Health Corporation (EHC) has been struggling lately, but the selling pressure may be coming to an end soon.
3 Medical Stocks Likely to Emulate Illumina's Success in 2019
by Urmimala Biswas
Illumina's (ILMN) gains are indeed staggering. But is it the sole star in the firmament setting benchmarks for others to try and emulate?
EHC vs. CHE: Which Stock Is the Better Value Option?
by Zacks Equity Research
EHC vs. CHE: Which Stock Is the Better Value Option?
Encompass Health Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Encompass Health has been struggling lately, but the selling pressure may be coming to an end soon.